Novacyt S.A. (NCYT.L)
Makes diagnostic tests and lab equipment for detecting diseases in humans and animals
36.62+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-7.4%
The outlook
NCYT.L is trading near the lower end of its 52-week range and below both its 50- and 200-day moving averages, signaling a downtrend. Analyst sentiment leans bearish overall, though the average price target sits roughly 80% above the current price, suggesting a significant disconnect between recent momentum and analyst expectations. Coverage appears limited or mixed given the bearish lean despite the elevated target.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +80% vs current price
Market cap
$26.6M
52-wk high
86.00
52-wk low
26.60
50-day avg
38.87
200-day avg
37.07
Trailing P/E
—